| A) | Rabies | ||
| B) | Tularemia | ||
| C) | Tinea cruris | ||
| D) | Liver flukes |
| A) | The 1920s | ||
| B) | The 1930s | ||
| C) | The 1940s | ||
| D) | The 1950s |
| A) | host. | ||
| B) | zooan. | ||
| C) | vector. | ||
| D) | carrier. |
| A) | reproduce. | ||
| B) | transmit disease. | ||
| C) | survive even briefly. | ||
| D) | Both A and B |
| A) | malaria. | ||
| B) | Lyme disease. | ||
| C) | Rocky Mountain spotted fever (RMSF). | ||
| D) | All of the above |
| A) | direct and indirect. | ||
| B) | direct and reservoir. | ||
| C) | indirect and complete. | ||
| D) | incomplete and complete. |
| A) | 1 | ||
| B) | 2 | ||
| C) | 3 | ||
| D) | 4 |
| A) | Giardiasis | ||
| B) | Amebiasis | ||
| C) | Balantidiasis | ||
| D) | Toxoplasmosis |
| A) | giardiasis. | ||
| B) | listeriosis. | ||
| C) | trichinosis. | ||
| D) | Lyme disease. |
| A) | Taenia solium | ||
| B) | Bacillus anthracis | ||
| C) | Rickettsia rickettsii | ||
| D) | Bartonella henselae |
| A) | lesion looking like impetigo. | ||
| B) | linear, raised rash of an erythema. | ||
| C) | macular, papular, flesh-colored rash. | ||
| D) | expanding bull's-eye lesion of erythema migrans. |
| A) | Within hours | ||
| B) | A few days | ||
| C) | Months to years | ||
| D) | Only after several years |
| A) | immune serum and culture. | ||
| B) | ELISA and Western blot tests. | ||
| C) | the Lyme urine antigen test (LUAT) and PCR. | ||
| D) | a rise in leukocyte count with a minimal increase in IgM. |
| A) | a carbapenem. | ||
| B) | watchful waiting. | ||
| C) | gentamicin and ciprofloxacin. | ||
| D) | either doxycycline, amoxicillin, or cefuroxime. |
| A) | typhoidal. | ||
| B) | pneumonic. | ||
| C) | oculoglandular. | ||
| D) | ulceroglandular. |
| A) | Bovar | ||
| B) | Typhoidal | ||
| C) | Oculoglandular | ||
| D) | Ulceroglandular |
| A) | RMSF. | ||
| B) | Q fever. | ||
| C) | Psittacosis. | ||
| D) | Murine typhus. |
| A) | 1 to 2 days | ||
| B) | 2 to 14 days | ||
| C) | 2 to 3 weeks | ||
| D) | 60 days |
| A) | pigs. | ||
| B) | birds. | ||
| C) | horses. | ||
| D) | mosquitoes. |
| A) | Less than 1% | ||
| B) | 5% | ||
| C) | 20% | ||
| D) | 50% |
| A) | MRI. | ||
| B) | CT scan. | ||
| C) | skull x-ray. | ||
| D) | nuclear medicine brain scan. |
| A) | between 10% to 20%. | ||
| B) | between 25% to 50%. | ||
| C) | between 50% to 75%. | ||
| D) | almost 100%. |
| A) | Antibody analysis of serum | ||
| B) | Immediate neuroimaging procedures | ||
| C) | Skin biopsy to examine nerves at the base of hair follicles | ||
| D) | Samples of brain tissue of animals to look for Negri bodies |
| A) | cell culture vaccine. | ||
| B) | rabbit globulin vaccine. | ||
| C) | human diploid cell vaccine. | ||
| D) | purified duck embryo vaccine. |
| A) | H1 | ||
| B) | H3 | ||
| C) | H4 | ||
| D) | H5 |
| A) | contact with infected poultry. | ||
| B) | eating cooked poultry products. | ||
| C) | contact with contaminated surfaces. | ||
| D) | aerosolized virus landing on the mouth, nose, or eye. |
| A) | Influenza A virus | ||
| B) | Influenza B virus | ||
| C) | Influenza N virus | ||
| D) | Influenza H virus |
| A) | less than one week. | ||
| B) | one to eight weeks. | ||
| C) | two months. | ||
| D) | one year. |
| A) | insidious onset. | ||
| B) | a flu-like illness lasting only a few days. | ||
| C) | rapid onset and very often fatal prognosis. | ||
| D) | severe and incapacitating fever and diarrhea. |
| A) | prion culture. | ||
| B) | brain biopsy or autopsy. | ||
| C) | a rise in specific antibody titers. | ||
| D) | extensive physical examination. |
| A) | cat. | ||
| B) | emu. | ||
| C) | elephant. | ||
| D) | water buffalo. |
| A) | cell culture. | ||
| B) | physical examination. | ||
| C) | brain biopsy of the patient. | ||
| D) | indirect immunofluorescent antibody tests |
| A) | is rarely necessary. | ||
| B) | is limited to supportive measures. | ||
| C) | should begin as soon as possible after diagnosis. | ||
| D) | None of the above |
| A) | chlorine. | ||
| B) | ultraviolet light. | ||
| C) | a filter less than 1 micron. | ||
| D) | Both A and C |
| A) | Glandular | ||
| B) | Inhalation | ||
| C) | Cutaneous | ||
| D) | Gastrointestinal |
| A) | an insect vector. | ||
| B) | germinating in an unexposed area. | ||
| C) | heat and ultraviolet light to stimulate the organism. | ||
| D) | the contamination of food or water by animals or people. |
| A) | prevent future cosmetic applications. | ||
| B) | reverse the existing clinical presentation. | ||
| C) | are only available for military personnel. | ||
| D) | only halt the progression of future symptoms. |
| A) | within 6 hours after ingestion of the infective organism. | ||
| B) | within 12 to 72 hours after ingestion of the infective organism. | ||
| C) | one week from the time of the ingestion of the infective organism. | ||
| D) | several weeks from the time of the ingestion of the infective organism. |
| A) | skin. | ||
| B) | liver. | ||
| C) | intestinal wall. | ||
| D) | skeletal muscle. |
| A) | No protection at all | ||
| B) | More protection than "blast freezing." | ||
| C) | Complete eradication of the organism | ||
| D) | Some prevention, but not enough to assure a completely safe product |